Page last updated: 2024-08-24

bromfenac and latanoprost

bromfenac has been researched along with latanoprost in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Kashiwagi, K; Tsukahara, S1
Lee, EK; Park, JH1

Trials

1 trial(s) available for bromfenac and latanoprost

ArticleYear
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.
    The British journal of ophthalmology, 2003, Volume: 87, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzophenones; Bromobenzenes; Drug Administration Schedule; Drug Interactions; Fluorescein Angiography; Humans; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic

2003

Other Studies

2 other study(ies) available for bromfenac and latanoprost

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Medical therapy for bilateral uveal effusion syndrome in nanophthalmos.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2017, Volume: 52, Issue:6

    Topics: Acetazolamide; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzophenones; Bromobenzenes; Carbonic Anhydrase Inhibitors; Choroid; Choroid Diseases; Ciliary Body; Drug Therapy, Combination; Fluorescein Angiography; Fundus Oculi; Humans; Latanoprost; Male; Microphthalmos; Middle Aged; Retina; Retinal Detachment; Syndrome; Tomography, Optical Coherence; Uveal Diseases

2017